What to know about orforglipron: an investigational oral GLP-1
For example, policies with in-patient-only benefits would be expected to have limited exposure to GLP-1 utilization because these drugs are mainly prescribed in the outpatient setting
Its structure comprises seven standardized files: demographic data (DEMO), medication records (DRUG), AE descriptions (REAC), patient outcomes (OUTC), reporter information (RPSR), drug therapy timelines (THER), and treatment indications (INDI) 14,18,19
Han MH, Hwang S-I, Roy DB, Lundgren DH, Price JV, Ousman SS, et al
Sermorelin is a 29-amino acid peptide analog of GHRH (growth hormone-releasing hormone)
Both showed benefit, but results were not broken down by medication